A phase I/II trial of the kinesin spindle protein (KSP) inhibitor SB-743921 administered on days I and 15 every 28 days without and with prophylactic G-CSF in non-Hodgkin or Hodgkin lymphoma Meeting Abstract


Authors: Gerecitano, J.; O'connor, O.; Van Deventer, H.; Hainsworth, J.; Leonard, J.; Goy, A.; Afanasyev, B.; Chen, M.; Saikali, K.; Conlan, M. G.; Escandon, R.; Wolff, A.
Abstract Title: A phase I/II trial of the kinesin spindle protein (KSP) inhibitor SB-743921 administered on days I and 15 every 28 days without and with prophylactic G-CSF in non-Hodgkin or Hodgkin lymphoma
Meeting Title: 50th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 112
Issue: 11
Meeting Dates: 2008 Dec 6-9
Meeting Location: San Francisco, CA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2008-11-16
Start Page: 554
Language: English
ACCESSION: WOS:000262104701784
PROVIDER: wos
PUBMED: 22276298
DOI: 10.1182/blood.V112.11.1563.1563
Notes: --- - Meeting Abstract: 1563 - Poster Session - 50th Annual Meeting of the American-Society-of-Hematology - DEC 06-09, 2008 - San Francisco, CA - "Source: Wos"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors